Title
Randomized control trial of losartan for inpatients with COVID-19
Published Date
2020-05-01
Authors
Group
University of Minnesota Department of Surgery
University of Minnesota Department of Emergency Medicine
Author Contact
Tignanelli, Christopher (ctignane@umn.edu)
Type
Dataset
Human Subjects Data
Abstract
The University of Minnesota Medical School is currently performing clinical research trials to find treatments for the COVID-19. One of the studies examines a blood pressure medication, losartan, to see if it can help alleviate the severity of the disease. This is a multi-center (M Health Fairview and Hennepin County Medical Center), double-blinded study of COVID-19 infected patients who will be randomized 1:1 to daily losartan or placebo for 10 days or until hospital discharge.
Description
Data and metadata are offered under a Creative Commons Zero Public Domain Dedication License
Funding information
Sponsorship:
Bill and Melinda Gates Foundation (Investment ID INV-017069)
Related to
Project Website
Collection: Covid-19 Clinical Trials
ClinicalTrials.gov Identifier: NCT04312009
License
CC0 1.0 Universal
Suggested Citation
Tignanelli, Christopher; Puskarich, Michael.
(2020). Randomized control trial of losartan for inpatients with COVID-19.
Retrieved from the Data Repository for the University of Minnesota,
https://hdl.handle.net/11299/212950.